Southeast Asian ride hailing service Grab has boosted an already swelling series H round to $4.8bn, taking in $300m from investment management firm Invesco.
Deutsche Telekom Capital Partners was launched by its parent company nearly five years ago, and has now formed a $350m second venture and growth capital fund.
Who says the IPO market is on the dip? Adaptive Biotechnologies – backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences – saw its share price double on its first day of trading – from $20 to $40.30 – while BridgeBio Pharma, which is developing drugs to treat diseases driven by genetic defects, floated above its range despite increasing the number of shares in its offering by a third.
On GUV, Commonwealth Fusion Systems (CFS), a US-based fusion power technology spinout of Massachusetts Institute of Technology (MIT), has closed a $115m series A round backed by MIT’s The Engine.
SpaceX is reportedly looking to raise more than $314m in its forthcoming round, with most or potentially all of it set to come from Ontario Teachers’ Pension Plan, which has confirmed it has invested in the GV-backed space services provider.
Ouyeel, an online trading platform spun off by China Baowu Steel, has raised $294m in a round featuring corporates Sinotrans, Benxi Group and Beijing Jianlong Heavy Industry as well as Baowu itself together with its Baoshan Iron and Steel subsidiary.
Digital manufacturing technology producer Carbon has received more than $260m in a round that pushed its overall funding past $680m.
Digital bank operator Monzo is going from strength to strength, helping to indicate that the UK’s Brexit woes have not affected its status as a centre of fintech.
StockX, the operator of an online marketplace for authenticated rare fashion items, has shown once again that the upmarket fashion space is an attractive one for investors. It has notched up $110m in a series C round featuring GV, which participated as an existing backer, at a valuation of more than $1bn.
Cardiac imaging technology provider Acutus Medical has secured $100m in series D funding from investors including GE Ventures as part of a larger round that included a $70m credit facility. Acutus has now raised roughly $230m in equity financing altogether, with GE Ventures having been an investor since at least 2013, and the funding will go to strengthening its atrial access product range.
That model of corporate venturing looks like it’s gaining some traction. Logistics services provider JD Logistics was spun off by e-commerce company JD.com two years ago but it is now getting into the corporate venturing game itself and has accumulated $218m for a strategic fund.
Fast fashion retail brand Miniso raised its first outside funding just eight months ago, having launched in 2013, but it is reportedly now gearing up for an initial public offering that could raise $1bn.
Upmarket fashion marketplace TheRealReal, proving it isn’t just the biotech sector that’s doing well, also completed a $300m initial public offering and went public on Friday.
Slack’s direct offering has pulled in the headlines but Stoke Therapeutics held its own successful listing last week, which it has now closed at just over $163m.
Atreca is working on immunotherapeutics to treat cancer, and raised $125m when it floated today, having priced the IPO at the midpoint of its range.
Velodyne Lidar is meanwhile pushing to become the first lidar technology developer to go public, having hired banks to underwrite an IPO expected to value it at about $1.8bn.